Business Context and Reporting Period
Company: Carpenter Technology Corporation (CRS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended December 31, 2025 (Fiscal Year 2026 Q2)
Business Overview: A producer and distributor of premium specialty alloys, including titanium, powder metals, stainless steels, and tool steels, serving aerospace, defense, medical, energy, and industrial markets. The company operates two segments: Specialty Alloys Operations (SAO) and Performance Engineered Products (PEP).
Key Financial Metrics
| Metric (in millions) | 3 Months Ended Dec 31, 2025 | 6 Months Ended Dec 31, 2025 | 6 Months Ended Dec 31, 2024 |
|---|---|---|---|
| Net Sales | $728.0 | $1,461.7 | $1,394.5 |
| Gross Profit | $218.3 | $434.7 | $353.8 |
| Gross Margin % | 30.0% | 29.7% | 25.4% |
| Operating Income | $155.2 | $308.6 | $232.5 |
| Operating Margin % | 21.3% | 21.1% | 16.7% |
| Net Income | $105.3 | $227.8 | $168.9 |
| Diluted EPS | $2.09 | $4.52 | $3.33 |
| Operating Cash Flow (6mo) | N/A | $171.4 | $108.1 |
| Adjusted Free Cash Flow (6mo) | N/A | $82.5 | $51.9 |
| Long-Term Debt | $690.1 | $690.1 | $695.4 |
| Cash & Equivalents | $231.9 | $231.9 | $162.1 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 8% year-over-year (Q2) and 5% for the six-month period, driven by price increases and improved product mix, particularly in Aerospace and Defense and Energy markets.
- Profitability Expansion: Operating income rose 31% in Q2 and 33% for the six-month period. Gross margins expanded significantly due to a shift toward higher-value materials and operational efficiencies.
- Debt Restructuring: In November 2025, the company issued $700 million in 5.625% Senior Notes due 2034 to refinance $700 million of existing debt (due 2028 and 2030). This resulted in a one-time debt extinguishment loss of $15.6 million recorded in the quarter.
- Segment Performance:
- SAO: Sales up 10% (Q2) and 6% (6mo); Operating income up 29% (Q2) and 28% (6mo). Achieved a record operating margin of 26.4% in Q2.
- PEP: Sales down 12% (Q2) and 10% (6mo) due to lower Medical and Distribution demand, though operating income remained stable.
- Working Capital: Cash used to build inventory decreased significantly to $27.9 million (6mo 2025) from $80.7 million (6mo 2024).
Guidance, Outlook, and Risks
- Outlook: Management expects continued growth driven by Aerospace and Defense demand (aging fleet replacement) and Energy sector strength (data center power generation). Long-term dynamics are viewed as strengthening.
- Capital Allocation:
- CapEx: Expected to be $300.0 million to $315.0 million for Fiscal 2026, including a brownfield expansion project.
- Share Repurchases: $81.2 million spent in the first six months of FY2026. $216.9 million remains available under the $400 million authorization.
- Dividends: Quarterly dividend of $0.20 per share maintained.
- Tax Environment: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 includes changes to R&D deductions and depreciation. Management does not expect a material impact on the effective tax rate.
- Risks & Contingencies:
- Tariffs: Company utilizes surcharge mechanisms to pass through raw material cost increases, including tariffs, and does not currently expect a material impact.
- Legal/Environmental: Routine litigation and environmental remediation liabilities ($17.5 million) are monitored; no material adverse effects are currently anticipated.
- Market Volatility: Exposure to raw material price fluctuations is managed via commodity forward contracts and surcharge mechanisms.
Investor Verification Checklist
- Debt Refinancing Impact: Verify the net benefit of the new 5.625% notes versus the redeemed higher-rate notes, excluding the one-time extinguishment loss.
- Non-GAAP Adjustments: Review the reconciliation of "Adjusted Operating Margin" and "Adjusted EPS" to understand the impact of excluding raw material surcharges and special items.
- Medical Segment Trends: Monitor the continued decline in Medical sales (down 18% Q2, 16% 6mo) due to supply chain inventory management.
- Capital Expenditure Execution: Track progress on the brownfield expansion project to ensure it aligns with the $300M-$315M FY2026 guidance.
- Liquidity Position: Confirm total liquidity of $730.8 million (Cash + Credit Facility availability) remains sufficient for operations and growth initiatives.